Contrary To Misinformation, COVID-19 Mortality And Hospitalization Has Been Rising In The Last 30 Days Globally. Please Take Precautions!

Source: SARS-CoV-2 Viral Persistence  Jun 02, 2022  8 months ago
BREAKING! Latest U.S. NIH Study Reveals Viral Persistence Is A Major Issue And That SARS-CoV-2 Replicates In Tissues For Months In Post-COVID Individuals!
facebook sharing button Share
twitter sharing button Tweet
linkedin sharing button Share
BREAKING! Latest U.S. NIH Study Reveals Viral Persistence Is A Major Issue And That SARS-CoV-2 Replicates In Tissues For Months In Post-COVID Individuals!
Source: SARS-CoV-2 Viral Persistence  Jun 02, 2022  8 months ago
A new study by researchers from the NIH COVID-19 Autopsy Consortium has shocking revealed that SARS-CoV-2 viral persistence is a major issue and that the SARS-CoV-2 virus continues to still replicate in tissues of Post-COVID individuals for months!

The study was led by Dr Daniel Chertow, a tenure-track investigator in the Critical Care Medicine Department at the NIH Clinical Center and in the Laboratory of Immunoregulation at the National Institute of Allergy and Infectious Diseases.
Among the key findings of the autopsy study viral persistence was detected almost all of the cases and that the virus was active in various organs and tissues of the human host. In some cases, SARS-CoV-2 RNA failed to clear from multiple anatomic compartments of the human host for up to 230 days (more than 7 months)!
The study showed that theSARS-CoV-2 virus disseminates across the human body and brain early in infection at high levels, and provide evidence of virus replication at multiple extrapulmonary sites during the first week following symptom onset.
The study detected viral sgRNA in at least one tissue in over half of cases (14/27) beyond 14 days, suggesting that prolonged viral replication may occur in extra-pulmonary tissues as late as 99 days.
This means that SARS-CoV-2 can replicate within human host tissue for over 3 months after infection in some individuals, with RNA failing to clear from multiple anatomic compartments for up to 230 days or maybe even longer!
The study also found that the virus infects the Central Nervous System (CNS) and brain of more than half of the cases.
The study also discovered the paucity of inflammation and direct viral cytopathology outside of the lungs. (In simple terms, the SARS-CoV-2 is attacking and damaging other tissues and organs!)
Other findings of the study indicated that the virus also mutates differently in the various tissues and organs. This resonates slightly with another past study.
Also, the study indicated that current ‘antivirals’ such as remdesivir etc does not stop viral persistence. (In fact, indicating that remdesivir exhibits nil antiviral efficacy!)
The study findings have enormous implications about Long COVID and also the medical conditions associated with such viral persistence in most Post COVID individuals.
In reality, we can now say that SARS-CoV-2 or COVID-19 is a disease that literally kills individuals slowly despite being deemed as recovered by current diagnostics and test!
The study findings are not yet published but were released in a video as part of the U.S. NIH–FDA COVID-19 SIG lecture. =45296?jwsource=twi">
Thailand Medical News has been warning about viral persistence since the early part of the pandemic.,-infections-pass-71-8-million-why-are-authorities-downplaying-viral-persistence
Despite an earlier U.S. NIH study published in December 2021, nothing much as been done to address this issue.
Other studies have also demonstrated SARS-CoV-2 viral persistence.
One study had also indicated the human male testes could be reservoirs for the SARS-CoV-2 virus while another by researchers from the University of California indicated that the brain could also serve as reservoirs for the SARS-CoV-2 virus!
Thailand Medical News also had warned that the Omicron variants are better evolved for continued viral persistence and new data emerging is also indicating this to be true.
Thailand Medical News has been researching for the last few months on the usage of certain phytochemical-based antivirals for complete SARS-CoV-2 clearance and also the proper mode of delivery of such antivirals to the deep human tissues. Our new product that is able to deal with whatever emerging variants uses a multi-pronged approach and a multi-antiviral approach and is currently available to only members of our newly launched premium service.
For more on SARS-CoV-2 Viral Persistence, keep on logging to Thailand Medical News.


Sep 25, 2022  4 months ago
Source: Medical News - SARS-CoV-2 Fall And Winter 2022 Variant Collections
Sep 08, 2022  5 months ago
Source- Medical News - COVID-19 Research - Impaired Pain Modulation
Aug 04, 2022  6 months ago
Source: Medical News - SARS-CoV-2 & Cancer
Aug 13, 2020  3 years ago
Source: Supplements For COVID-19
Feb 05, 2020  3 years ago
Source : Thailand Medical news